-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$15.001400% Upside
Angion Biomedica Corp. Frequently Asked Questions
-
What analysts cover Angion Biomedica Corp.?
Angion Biomedica Corp. has been rated by research analysts at Stifel Nicolaus in the past 90 days.